A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds

Journal of Dermatological Science

Volumn 59, Issue 3, 2010, Pages 170-175

  Yamamoto, Tetsuya ^a   Takata Michigami, Mikiko ^a   Hisamatsu, Yoshiko ^a   Yamamoto, Takenobu ^a   Hamada, Toshihisa ^a   Fujii, Kazuyasu ^a   Fujimoto, Wataru ^b   Taneichi, Koji ^c   Aoyama, Yumi ^a   Iwatsuki, Keiji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c Kitami Red Cross Hospital   (Japan)

Author keywords

Desmoglein; Non pathogenic; Pemphigus; Rheumatoid arthritis; Thiol

Indexed keywords

AURANOFIN; BUCILLAMINE; DESMOGLEIN 1; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3; DESMOGLEIN 3 ANTIBODY; EDETIC ACID; EPITOPE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; THIOL DERIVATIVE;

ACANTHOLYSIS; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; ESOPHAGUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MONKEY; PEMPHIGUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCREENING TEST; SJOEGREN SYNDROME; SKIN; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ACANTHOLYSIS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DESMOGLEIN 1; DESMOGLEIN 3; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; PEMPHIGUS; POLYMYOSITIS; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SULFHYDRYL COMPOUNDS; YOUNG ADULT;

EID: 77956178349     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.06.007     Document Type: Article

References (23)

1. Bialy-Golan A., Brenner S. Penicillamine-induced bullous dermatoses. J Am Acad Dermatol 1996, 35:732-742.
2. Mutasim D.F., Pelc N.J., Anhalt G.J. Drug-induced pemphigus. Dermatol Clin 1993, 11:463-471.
3. Brenner S., Bialy-Golan A., Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998, 16:393-397.
4. Patterson C.R.S., Davies M.G. Carbamazepine-induced pemphigus. Clin Exp Dermatol 2003, 28:98-99.
5. Korman N., Eyre R.W., Zone J., Stanley J.R. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 1991, 96:273-276.
6. Yokel B.K., Hood A.F., Anhalt G.J. Induction of acantholysis in organ explant culture by penicillamine and captopril. Arch Dermatol 1989, 125:1367-1370.
7. Troy J.L., Silvers D.N., Grossman M.E., Jaffe I.A. Penicillamine-associated pemphigus: is it really pemphigus?. J Am Acad Dermatol 1981, 4:547-555.
8. Ruocco V., Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 1991, 30:307312.
9. Ueki H., Kohda M., Nobutoh T., Yamaguchi M., Omori K., Miyashita Y., et al. Antidesmoglein autoantibodies in silicosis patients with no bullous diseases. Dermatology 2001, 202:16-21.
10. Yoshimura T., Seishima M., Nakashima K., Yasuhara Y., Adachi S., Kawaguchi M., et al. Increased antibody levels to desmogleins l and 3 after administration of carbamazepine. Clin Exp Dermatol 2001, 26:441-445.
11. Fleischmann M., Celerier P., Bernard P., Litoux P., Dreno B. Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology 1996, 192:50-55.
12. Tsunoda K., Ota T., Aoki M., et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003, 170:2170-2178.
13. Bhol K., Natarjan K., Nagarwalla N., Mohimen A., Aoki V., Ahmed A.R. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA 1995, 92:5239-5243.
14. Hacker M.K., Janson M., Fairley J.A., Lin M.S. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Clin Immunol 2002, 105:64-74.
15. Warren S.J.P., Lin M.S., Giudice G.L., et al. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. N Engl J Med 2000, 343:23-30.
16. Li N., Aoki V., Hans-Filho G., Rivitti E.A., Diaz L.A. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (Fogo Selvagem). J Exp Med 2003, 197:1501-1510.
17. Yokouchi M., Saleh M.A., Kuroda K., et al. Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 2009, 129:2156-2166.
18. Sharma P.M., Choi E.J., Kuroda K., Hachiya T., Ishii K., Payne A.S. Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3. J Invest Dermatol 2009, 129:2309-2312.
19. Amagai M., Komai A., Hashimoto T., Shirakata Y., Hashimoto K., Yamada T., Kitajima Y., Ohya K., Iwanami H., Nishikawa T. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999, 140:351-357.
20. Veldman C., Staber A., Wassmuth R., Uter W., Schuler G., Hertl M. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol 2003, 170:635-642.
21. Nagao K., Tanikawa A., Yamamoto N., Amagai M. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of d-penicillamine in drug-induced pemphigus foliaceus. Clin Exp Dermatol 2005, 30:43-45.
22. Hashimoto K., Singer K., Lazarus G.S. Penicillamine-induced pemphigus. Arch Dermatol 1984, 120:762-764.
23. Wolf R., Ruocco V. Gaining more insight into the pathomechanisms of thiol-induced acantholysis. Med Hypotheses 1997, 48:107-110.